复方丹参注射液合血活素治疗高血压脑出血疗效观察

Observation on therapeutic effect of Compound Danshen Injection and Deproteinized Calf-blood Extractives on patients with hypertensive cerebral hemorrhage

目的 :评价复方丹参注射液 (丹参 )在急性高血压脑出血中的治疗作用。方法 :将受治的 6 3例高血压脑出血患者(年龄 5 6～ 78岁 ,平均 6 1.9岁 )。在常规治疗的基础上 ,随机分为 3组 :复方丹参加血活素组 ,立止血加血活素组 ,单用血活素组。观察各组临床疗效、血肿吸收率、ADP诱导的血小板聚集率 (ADP pag)和凝血酶原时间 (PT)等指标。 结果 :采用格拉斯哥预后评分 (GOS)方法 ,复方丹参组中恢复良好和中等残疾 (GR +MD)者占 83.34% ,立加血组为 4 7.6 1% ,单用血活素组为 6 1.11% ,经Ridit检验 ,有显著性差异 (P <0 .0 5 ) ,复方丹参组疗效最佳 ,其血肿吸收率与其他两组比较 ,经Ridit检验 ,有显著性差异 (P <0 .0 5 )。复方丹参组不影响血小板凝血功能 ,ADP pag、PT值在正常范围。 结论 :复方丹参注射液是一种治疗急性高血压性脑出血安全有效药物 ,值得临床推广应用。

Objective: To assess the effect of Compound Danshen(CD) Injection (Radix Salviae Militiorrhizae) in the treatment of hypertensive cerebral hemorrhage (HCH). Methods : Sixty-three cases (aged 56～78, 61.9 years on average) with HCH were randomly divided into three groups: (CD+Deproteinized Calf-blood Extractives (DCE) group and Reptilase+DCE group as the treated groups, DCE group as the control group) to observe the outcome of the clinical treatment, hematoma absorbability and changes of ADP-platelet agglutination rate (Pag) and prothrombin time (PT). Results : The rate of the good result (GR) and moderate disability (MD) in CD group was 83.34% with the method of Glasgow outcome score (GOS), others were 47.61% and 61.11% ,respectively. they have significant difference, P <0.05. Among them, CD group had best result. Compared the rate of hematoma absorbability of CD group with that of Reptilase, DCE groups, the difference was significant, P < 0.05 . It did not affect the platelet coagulative function in CD group. Conclusion : CD Injection could effectively improve the condition of patients with HCH, and with little side effect, It is worthwhile to be used in the clinical practice.